Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: Mechanisms of action: Other Review

Obesity Reviews

Volumn 10, Issue 3, 2009, Pages 342-349

  Dang, Z C ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

ERs; Isoflavone; Obesity; PPARs

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FUNCTION; CONCENTRATION RESPONSE; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HUMAN; NONHUMAN; OBESITY; PLEIOTROPY; REVIEW; SOYBEAN;

ADIPOCYTES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENISTEIN; HUMANS; MALE; PHYTOESTROGENS;

EID: 65349162111     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2008.00554.x     Document Type: Review

References (54)

1. James WP. The fundamental drivers of the obesity epidemic. Obes Rev 2008 9 (Suppl. 1 6 13.
2. Crombie IK, Irvine L, Elliott L, Wallace H. Targets to tackle the obesity epidemic: a review of twelve developed countries. Public Health Nutr 2008 1 8 Epub ahead of print A, Dyerberg J, Selleck M, Stender S. Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes Rev 2008 9 (Suppl. 1 48 52.
3. Cope MB, Erdman JW. Jr., Allison, DB. The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes Rev 2008 9 : 219 235.
4. Orgaard A, Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med (Maywood) 2008 233 : 1066 1080.
5. Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 2008 19 : 717 726.
6. Dang ZC, Lowik C. Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol Metab 2005 16 : 207 213. (Pubitemid 40853883)
7. Setchell KD. Assessing risks and benefits of genistein and soy. Environ Health Perspect 2006 114 : A332 A333. (Pubitemid 43871713)
8. Chen A, Rogan WJ. Isoflavones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annu Rev Nutr 2004 24 : 33 54. (Pubitemid 38938785)
9. Jefferson WN, Padilla-Banks E, Newbold RR. Disruption of the developing female reproductive system by phytoestrogens: genistein as an example. Mol Nutr Food Res 2007 51 : 832 844. (Pubitemid 47173693)
10. Penza M, Montani C, Romani A, Vignolini P, Pampaloni B, Tanini A, Brandi ML, Alonso-Magdalena P, Nadal A, Ottobrini L, Parolini O, Bignotti E, Calza S, Maggi A, Grigolato PG, Di Lorenzo D. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 2006 147 : 5740 5751.
11. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin Mol Teratol 2005 73 : 478 480. (Pubitemid 41045293)
12. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CW. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003 278 : 962 967. (Pubitemid 36790772)
13. Cooke PS, Naaz A. Effects of estrogens and the phytoestrogen genistein on adipogenesis and lipogenesis in males and females. Birth Defects Res A Clin Mol Teratol 2005 73 : 472 473. (Pubitemid 41045290)
14. Wang H, Malbon CC. G (s)alpha repression of adipogenesis via Syk. J Biol Chem 1999 274 : 32159 32166. (Pubitemid 129503812)
15. Liao QC, Li YL, Qin YF, Quarles LD, Xu KK, Li R, Zhou HH, Xiao ZS. Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity. J Cell Biochem 2008 104 : 1853 1864.
16. Dang ZC, Lowik CW. Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway. Mol Cell Biochem 2005 268 : 159 167. (Pubitemid 40287838)
17. Rimbach G, Boesch-Saadatmandi C, Frank J, Fuchs D, Wenzel U, Daniel H, Hall WL, Weinberg PD. Dietary isoflavones in the prevention of cardiovascular disease - a molecular perspective. Food Chem Toxicol 2008 46 : 1308 1319.
18. Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 2002 17 : 394 405. (Pubitemid 34171754)
19. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y, Matsumoto T. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 2002 143 : 2349 2356. (Pubitemid 34521581)
20. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004 145 : 848 859. (Pubitemid 38183829)
21. Shen P, Liu MH, Ng TY, Chan YH, Yong EL. Differential effects of isoflavones, from astragalus membranaceus and pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 2006 136 : 899 905.
22. Harmon AW, Patel YM, Harp JB. Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J 2002 367 : 203 208. (Pubitemid 35176907)
23. Park HJ, Della-Fera MA, Hausman DB, Rayalam S, Ambati S, Baile CA. Genistein inhibits differentiation of primary human adipocytes. J Nutr Biochem 2008 Epub ahead of print L, Zang H, Hirschberg AL, Gustafsson JA, Arner P, Dahlman-Wright K. Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 2008 90 : 44 48.
24. Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 2000 75 : 265 271. (Pubitemid 32244256)
25. Harmon AW, Harp JB. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 2001 280 : C807 C813. (Pubitemid 32472320)
26. Lephart ED, Setchell KD, Handa RJ, Lund TD. Behavioral effects of endocrine-disrupting substances: phytoestrogens. ILAR J 2004 45 : 443 454.
27. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003 144 : 3315 3320. (Pubitemid 36904405)
28. Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, Zeisel SH. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 2002 76 : 1126 1137. (Pubitemid 35244688)
29. Kim HK, Nelson-Dooley C, Della-Fera MA, Yang JY, Zhang W, Duan J, Harzell DL, Hamrick MW, Baile CA. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 2006 136 : 409 414. (Pubitemid 43228294)
30. Yang JY, Lee SJ, Park HW, Cha YS. Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. J Med Food 2006 9 : 459 467. (Pubitemid 46095352)
31. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl 2008 31 : 201 208.
32. Ruhlen RL, Howdeshell KL, Mao J, Taylor JA, Bronson FH, Newbold RR, Welshons WV, vom Saal FS. Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the fetal estrogenization syndrome and obesity in CD-1 mice. Environ Health Perspect 2008 116 : 322 328.
33. Cederroth CR, Vinciguerra M, Kuhne F, Madani R, Doerge DR, Visser TJ, Foti M, Rohner-Jeanrenaud F, Vassalli JD, Nef S. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ Health Perspect 2007 115 : 1467 1473. (Pubitemid 47618089)
34. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006 114 : 567 572.
35. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998 139 : 4252 4263. (Pubitemid 28513713)
36. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001 24 : 351 356. (Pubitemid 32377601)
37. Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000 19 : 4970 4978.
38. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001 276 : 17808 17814. (Pubitemid 37411337)
39. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000 351 : 95 105.
40. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 2000 60 : 1051 1059.
41. Dang ZC, Lowik CW. Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis. J Cell Biochem 2004 92 : 525 533.
42. Kato S, Masuhiro Y, Watanabe M, Kobayashi Y, Takeyama KI, Endoh H, Yanagisawa J. Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways. Genes Cells 2000 5 : 593 601. (Pubitemid 30641952)
43. Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene 2002 21 : 4000 4008. (Pubitemid 34679241)
44. Lu Q, Ebling H, Mittler J, Baur WE, Karas RH. MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor alpha. FEBS Lett 2002 516 : 1 8. (Pubitemid 34311922)
45. Ferry G, Bruneau V, Beauverger P, Goussard M, Rodriguez M, Lamamy V, Dromaint S, Canet E, Galizzi JP, Boutin JA. Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands. Eur J Pharmacol 2001 417 : 77 89. (Pubitemid 32303195)
46. Chacko BK, Chandler RT, Mundhekar A, Khoo N, Pruitt HM, Kucik DF, Parks DA, Kevil CG, Barnes S, Patel RP. Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 2005 289 : H908 H915. (Pubitemid 41129409)
47. Shi Y, Hon M, Evans RM. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci USA 2002 99 : 2613 2618. (Pubitemid 34240509)
48. Dang Z, Lowik CW. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res 2004 19 : 853 861. (Pubitemid 41094397)
49. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal 2003 15 : 355 366. (Pubitemid 36254908)
50. Diradourian C, Girard J, Pegorier JP. Phosphorylation of PPARs: from molecular characterization to physiological relevance. Biochimie 2005 87 : 33 38. (Pubitemid 40298763)
51. Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karaplis AC. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology 2001 142 : 4900 4909. (Pubitemid 33022366)
52. Wang X, Kilgore MW. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 2002 194 : 123 133. (Pubitemid 35291927)
53. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine Leiomyoma. Cancer Res 2003 63 : 1221 1227. (Pubitemid 36348698)
54. Lavigne JA, Takahashi Y, Chandramouli GV, Liu H, Perkins SN, Hursting SD, Wang TT. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study. Breast Cancer Res Treat 2008 110 : 85 98.